Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 441, 22-23 (4 May 2006) | doi:10.1038/441022a; Published online 3 May 2006
The quiet rise of the clinical contractor
Top of page
Abstract
More and more drug trials are being farmed out to contractors, but who's benefiting from the change? Meredith Wadman investigates.
When a big US drug company needed to get a late-stage breast-cancer trial launched quickly some years ago, it turned to PRA International, one of a dozen major contract-research organizations (CROs) that now permeate the worldwide drug industry.PRA is headquartered in a nondescript office building outside Washington, DC.
To read this story in full you will need to login or make a payment (see right).